Hormone therapy for postmenopausal women
Evidence is mounting that hormone therapy (HT) after menopause is not associated with increased risks, despite earlier concerns. A recent meta-analysis of a number of
Evidence is mounting that hormone therapy (HT) after menopause is not associated with increased risks, despite earlier concerns. A recent meta-analysis of a number of
The topic of male contraception was covered in an article by Kristen Fawcett for US News and World Report. Vasalgel and Clean Sheets Pill were
Vasalgel has enjoyed significant media presence recently which is continuing into 2015. The Santa Fe Reporter highlighted the advancements that Vasalgel promises to bring to
Elaine Lissner, Director of Parsemus Foundation, was interviewed by ABC TV news – San Francisco. The piece focused on the development of Vasalgel and aired
Common birth control pills called combined oral contraceptives (COC) contain ethinyl-estradiol, a derivative of the estradiol found in the body. COCs are known to raise
Standard treatment for women who have had breast cancer is anti-estrogen therapy using aromatase inhibitors. But this treatment has serious implications for cardiovascular and bone
The Vasalgel project enjoys a tremendous following from individuals across the world interested in better options for male contraception. One of our supporters translated information
Our recent news update prompted a great deal of media attention, ranging from national and international news outlets to local newspapers. Vasalgel was even mentioned
Women were more likely to discontinue taking aromatase inhibitors if the out-of-pocket costs were higher, a research study suggested. Generic drugs, which have lower copayments,
A new research study found that hormone therapy following breast cancer had significant benefits in terms of greater physical activity, improved cognition, and better cardiovascular
And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well: